AI’s Impact on Healthcare: From Innovation to Implementation
AI’s Impact on Healthcare: From Innovation to Implementation
– This session will examine how artificial intelligence is changing healthcare today and
how it may transform clinical practice, research, operations, medical education, and
therapeutic development in the years ahead.
– The discussion will address AI-enabled diagnosis, clinical decision support, drug
discovery, patient monitoring, documentation, workflow automation, regulatory
oversight, bias, trust, data privacy, and physician accountability.
– Panelists will focus on both the promise and the risks of AI, with particular attention to
how AI can improve outcomes, reduce burden, and expand access while preserving
safety, transparency, and the human dimension of medicine.
MODERATOR:
Jeffrey Hausfeld, M.D., M.B.A.
Chairman of the Board and Chief Medical Officer at BioFactura, Inc. & Chairman and Founder of the Society of Physician Entrepreneurs
Jeffrey Hausfeld, M.D., M.B.A., F.A.C.S., has served on the national board and committees of specialty medical societies since he began his practice in Otolaryngology/Facial Plastic Surgery in 1982. He is an Associate Clinical Professor of Surgery at George Washington University School of Health Sciences and an alumnus of the Yale University School of Medicine. Dr. Hausfeld is widely published in the medical literature, is the pioneer of innovative laser surgery techniques, is the author of a lay oriented medical book on snoring and sleep apnea, and has appeared on numerous local and national television and radio shows as a medical expert. Read full profile…
PANELISTS:
Mike McLaughlin
Head of AI/ML & Advanced Analytics, Enterprise Data and Analytics, Children’s National Hospital
Mike is a recognized leader in artificial intelligence, bringing more than a decade of experience building and leading high-performing AI and advanced analytics teams. Throughout his career, he has operated at the forefront of healthcare innovation, combining AI, data science, and advanced analytics to drive meaningful clinical and operational impact. Read full profile…
Dr. Chung Hyuk Park
Associate Professor, The George Washington University | Socially Assistive Robotics, Human-Robot Interaction
Dr. Chung Hyuk Park is a Professor in the Department of Biomedical Engineering, School of Engineering and Applied Science at the George Washington University. As the director of the Assistive Robotics and Tele-Medicine (ART-Med) Lab, his current research interests are: 1) Multimodal human-robot interaction (HRI) and robotic assistance for individuals with disabilities or special needs, 2) Robotic learning and humanized intelligence, 3) Tele-medical robotic assistance and AI-based reasoning for medical perception and decision-making, 4) Trustworthiness in Embodied AI, and 5) Physical AI and Neuro-Sybolic Learning. Read full profile…
Shashank J. Patel, Ph.D.
Founder & Chief Executive Officer, Monocacy Therapeutics Inc.
Dr. Shashank J. Patel is an immunologist, gene-engineer, and biotech entrepreneur with more
than 15 years of leadership experience spanning academia, government, and global biopharma. He is the Founder and CEO of Monocacy Therapeutics Inc., an AI-native immunotherapy company pioneering first-in-class small molecules and engineered biologics to overcome resistance to immune checkpoint therapy and expand access to transformative cancer treatments. Read full profile…
Ryan Schmaltz
Co-Founder and CEO of ReadyAI (Formerly Patient Ready)
Ryan Schmaltz is the co-founder and CEO of ReadyAI (formerly Patient Ready), a workforce intelligence company helping organizations build workforces that can perform as AI changes how work gets done. He has led major technology, innovation, and growth initiatives at Uber, Microsoft, Adobe, and Deloitte, including helping companies launch and scale globally. Read full profile…
Vijay Walia, PhD MBA
Sr. Director, Regulatory Affairs at Quest Diagnostics
Dr. Vijay Walia is a Sr. Director, Regulatory Affairs at Quest Diagnostics leading regulatory strategy for oncology and software-based devices. Dr. Walia is an expert in US FDA negotiations, Breakthrough Designations, PMA, DeNovo, 510(k), pre-submissions, Design Controls, AI-based devices, and Software & Cybersecurity for IVDs and Medical Devices. Dr. Walia is an expert in US FDA negotiations, Breakthrough Designations, PMA, DeNovo, 510(k), pre-submissions, Design Controls, AI-based devices, and Software & Cybersecurity for IVDs and Medical Devices. Read full profile…